Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease

CONTEXT: High levels of the phosphate regulating hormone, fibroblast growth factor 23 (FGF23), associate with mortality in patients with end-stage renal disease (ESRD), but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Isakova, Tamara, Xie, Huiliang, Yang, Wei, Xie, Dawei, Anderson, Amanda Hyre, Scialla, Julia, Wahl, Patricia, Gutiérrez, Orlando M., Steigerwalt, Susan, He, Jiang, Schwartz, Stanley, Lo, Joan, Ojo, Akinlolu, Sondheimer, James, Hsu, Chi-yuan, Lash, James, Leonard, Mary, Kusek, John W., Feldman, Harold I., Wolf, Myles
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124770/
https://ncbi.nlm.nih.gov/pubmed/21673295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.826
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados